The HealthPartners Institute Cancer Research Center (CRC) delivers the latest oncology research services typically found only at leading academic health care institutions. With a strong focus on quick responsiveness and rapid turnaround, the CRC maintains an active pipeline of phase I through phase III clinical trials, and investigator-initiated studies, consistently approving 3-4 new studies each month. Our mission is to benefit patients through innovative cancer care that integrates clinical research and quality improvement into routine care—close to home.

Our systemwide cancer centers also participate in the Metro Minnesota Community Oncology Consortium (MMCORC), a nonprofit research program sponsored by the National Cancer Institute (NCI).  MMCORC’s mission is to provide the opportunity for patients to enroll in a high-quality clinical trial for the treatment or prevention of cancer in their own community while being treated by a local physician. Two of our HealthPartners Cancer Centers (HealthPartners Cancer Center at Regions Hospital and HealthPartners Frauenshuh Cancer Center) are the top accruing sites for the consortium, which recently received the platinum level award from NCI for high enrollment. 

HealthPartners Cancer Care includes approximately 40 medical oncologists geographically distributed across the Twin Cities. Our medical oncologists are trained in hematology/oncology and support our clinical research by serving as sub-investigators on trials, reviewing incoming trial opportunities, and developing novel clinical research questions. Listed below are the clinician investigators who serve as principal investigators on our trials.